文献速递药疹与重症皮肤不良反应

史蒂文斯-约翰逊综合征与中毒性表皮坏死松解症幸存者的康复体验:一项质性研究

Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
PubMed 文献 · JAMA Dermatol · 2026-01-01

该研究通过半结构化深度访谈,探讨美国29名SJS/TEN成年幸存者出院后的长期生物心理社会影响。幸存者出院后普遍感到孤立无援,经历持续的皮肤问题、视力损害等躯体症状,以及焦虑、抑郁等心理影响,并指出缺乏出院教育和医生对SJS/TEN的认识不足。研究强调需在出院前协调初级医生和心理支持等出院后护理。

要点

  • SJS/TEN幸存者出院后常感孤立,缺乏针对长期后遗症的持续支持。
  • 幸存者经历皮肤问题、视力损害等持续躯体症状及焦虑、抑郁等心理影响。
  • 出院前应协调好出院后护理,包括心理健康支持,并加强医生对SJS/TEN的认识。

核心结论

  • SJS/TEN幸存者出院后面临显著的生物心理社会长期影响,亟需出院后护理协调和针对性的出院教育。

研究设计与样本

  • 基于社区研究的质性调查,采用半结构化深度访谈指南,于2021年7月至2023年8月通过电话访谈美国29名经历过SJS/TEN的成年人。

主要发现

  • 29名参与者年龄26至76岁,66%为女性,69%为白人,SJS/TEN由多种药物引起。
  • 住院期间患者获得支持,但出院后感到孤立,缺乏对SJS/TEN潜在持续影响的了解和支持。
  • 患者经历持续的生物学症状,如皮肤问题、致衰性视力损害、失明和缺乏功能自主性。
  • 心理影响包括焦虑、强迫思维、闪回和抑郁症状;社会方面,部分幸存者感到被抛弃并描述对职业生涯的负面影响。
  • 幸存者对独自应对出院后护理感到沮丧和孤立,缺乏预防性出院教育和SJS/TENspecific规划,并指出医生对SJS/TEN知识不足,常转向互联网寻求指导,医疗不信任常被提及。

临床怎么用

  • 临床应重视SJS/TEN幸存者的长期后遗症,在出院前协调好患者与初级医生的出院后护理,包括心理健康支持。
  • 改进当前的出院教育和方案,确保患者及其家庭获得充分支持以优化健康结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) survivors experience substantial long-term sequelae. Research on physical symptoms experienced during acute hospitalization is well documented, but limited studies have been completed on the long-term biopsychosocial effects of SJS/TEN, particularly from the patient's perspective. OBJECTIVE: To increase the understanding of the long-term complications of SJS/TEN. DESIGN, SETTING, AND PARTICIPANTS: This qualitative investigation was completed from within a community-based study, the SJS Survivors Study, using a semistructured, in-depth interview guide to query participants about their SJS/TEN experience postdischarge from the hospital. Interviews took place by phone from July 2021 through August 2023. This study included adults who experienced SJS/TEN within the United States. MAIN OUTCOME AND MEASURES: A biopsychosocial theory-based framework and hierarchical coding system were utilized to understand the long-term life impacts of survivors of SJS/TEN. RESULTS: The 29 participants, aged 26 to 76 years, were 66% female and 69% White and had experienced SJS/TEN from a wide range of drugs. Patients experienced support while in the hospital, but once discharged, felt isolated and without support to understand the potential sustained impacts of SJS/TEN in their lives and the lives of their family members. Patients experienced ongoing biological symptoms, such as skin issues, debilitating visual impairment, blindness, and lack of functional autonomy. Psychological impacts included symptoms of anxiety, obsessive thinking, flashbacks, and depression. Socially, some survivors expressed a sense of abandonment and described negative impacts on their careers. Survivors also expressed frustration and isolation with having to navigate posthospital care alone. There was a lack of preemptive discharge education and SJS/TEN-specific planning. Lack of physician knowledge about SJS/TEN was particularly noted and survivors turned to the internet for guidance instead of receiving direction from their physicians. Medical distrust among survivors was frequently noted. CONCLUSIONS AND RELEVANCE: The findings highlight the need for postdischarge care coordination among patients and their primary physicians, including mental health support. This care coordination should be arranged prior to discharge to ensure the availability of adequate support and optimal health outcomes. It is essential that clinicians and researchers prioritize the understanding of long-term sequelae of SJS/TEN and improve current discharge education and protocols for patients and their families.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Martin-Pozo MD, Williams EA, Bonnet KR, et al. Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatol. 2026. PMID: 41222950. doi:10.1001/jamadermatol.2025.4345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。